CASI Pharmaceuticals (CASIF) Assets (2021 - 2025)
CASI Pharmaceuticals' (CASIF) quarterly Assets came in at $25.6 million in Q4 2025, down 52.21% YoY from $53.7 million in Q4 2024, and up 4.86% on a QoQ basis from $24.5 million in Q3 2025.
CASI Pharmaceuticals (CASIF) Assets (2021 - 2025) Analysis & Trends
CASI Pharmaceuticals (CASIF) has 5 years of Assets data on file, last reported at $25.6 million in Q4 2025.
- Quarterly Assets fell 52.21% year-over-year to $25.6 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $25.6 million (down 52.21% YoY) and the FY2025 annual result came in at $25.6 million, down 52.21% from the prior year.
- Assets climbed to $25.6 million in Q4 2025, from $24.5 million in the prior quarter.
- In the past five years, Assets ranged from a high of $138.3 million in Q4 2021 to a low of $40821.0 in Q1 2025.
- A 5-year average of $47.2 million and a median of $42.4 million in 2024 frame the typical range for Assets.
- The widest YoY moves for Assets: up 60757.01% in 2025, down 99.93% in 2025.
- Tracing CASIF's Assets over 5 years: stood at $138.3 million in 2021, then slumped by 30.42% to $96.2 million in 2022, then slipped by 21.79% to $75.3 million in 2023, then retreated by 28.69% to $53.7 million in 2024, then plunged by 52.21% to $25.6 million in 2025.
- The last three Assets figures came in at $25.6 million (Q4 2025), $24.5 million (Q3 2025), and $31.2 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 27.42 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 41.73 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 10.03 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 10.96 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 9.18 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 5.56 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 25.60 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 2.10 Bn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 19.82 Bn |
| 10 | CASI Pharmaceuticals | 2.65 Mn | -3.76 Bn | - | 21.06 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 25.65 Mn |
| Sep 30, 2025 | 24.46 Mn |
| Jun 30, 2025 | 31.20 Mn |
| Mar 31, 2025 | 40,821.00 |
| Dec 31, 2024 | 53.67 Mn |
| Sep 30, 2024 | 63.62 Mn |
| Jun 30, 2024 | 51,271.00 |
| Mar 31, 2024 | 58.01 Mn |
| Dec 31, 2023 | 75.27 Mn |
| Jun 30, 2023 | 77,874.00 |
| Dec 31, 2022 | 96.23 Mn |
| Dec 31, 2021 | 138.30 Mn |